BNTX Overview
Upcoming Projects (BNTX)
-
Investigating the phase 2 clinical trial data on BNT327/PM8002 Combined with Chemotherapy for Extensive-Stage Small Cell Lung Cancer (ES-SCLC)
Ticker: BNTX
Scheduled For: Apr 29, 2025 at 03:00 PM EDT
Executed Projects (BNTX)
-
A look at BNT327, a bispecific antibody in development by BioNTech, and the results presented at the ESMO Congress in patients with NSCLC
Ticker: BNTX
Executed On: Oct 08, 2024 at 02:00 PM EDT -
Examining the potential of BioNTech/DualityBio' DB-1303 in patients with advanced/metastatic solid tumors after receiving fast track designation
Tickers: BNTX, Duality Bio
Executed On: Oct 20, 2023 at 11:00 AM EDT -
A look into the proposed mRNA-based vaccine for the prevention of Shingles
Tickers: BNTX, PFE
Executed On: May 24, 2022 at 02:00 PM EDT
Upcoming & Overdue Catalysts (BNTX)
-
Don’t see a catalyst related to the company you care about? Create your own!
Occurred Catalysts (BNTX)
-
Pfizer/BioNTech's BNT162b2 vaccine against SARS-CoV-2 U.S. EUA application expected this month
Tickers: PFE, BNTX
Occurred on: Nov 20, 2020 -
EU in talks with Moderna, BioNtech, Sanofi, Johnson & Johnson and CureVac to secure possible COVID vaccines
Tickers: JNJ, SNY, BNTX, MRNA
Occurred on: Jul 17, 2020
Strategic Initiatives (BNTX)
-
Don’t see a strategic initiative related to the company you care about? Create your own!
